The Ensign Group Inc "Further Perspective on Recent Questions Regarding..."

Research evidence excerpt

The Ensign Group Inc "Further Perspective on Recent Questions Regarding..."

Global Research

11 June 2026ab

The Ensign Group Inc Equities

United StatesFurther Perspective on Recent Questions

Regarding Company Staffing and Quality Healthcare Providers

12-month rating Buy

12m price target US$230.00Management Check-In Takeaways; Addresses Questions in the Market Today

We wanted provide additional information as a follow-up to our report dated June 8th

(see here), in response to continued investor questions. We provide some incremental Price (10 Jun 2026) US$151.65

details below to help investors better understand ENSG's staffing metrics, quality, and RIC: ENSG.O BBG: ENSG US

reimbursement rates. As a reminder, the nursing home industry has faced many

challenges over time. The sector deals with elderly, often frail, patients and has Trading data and key metrics

periodically had to deal with funding challenges with the states under Medicaid and 52-wk range US$215.83-136.36

with the Federal government under Medicare. Those industry challenges were Market cap. US$8.99b

substantially exasperated during the years of the Covid pandemic public health Shares o/s 59.3m (COM)

emergency from 2020 to 2023, when staffing levels became very challenging, a factor Free float 96%

widely recognised by government authorities. Drawing conclusions from data related to Avg. daily volume ('000) 508

the 2020-23 period could in our view lead to unwarranted conclusions about the Avg. daily value (m) US$91.9

current and future state of the business. Common s/h equity (12/26E) US$2.71b

P/BV (12/26E) 3.3x

Addressing Insufficient Staffing Concerns Net debt to EBITDA (12/26E) 2.1x

One of the main investor questions has been around ENSG understaffing facilities based

on Payroll Based Journal (PBJ) data.